Table 1 Demographic and clinical characteristics of the patients that suffered from acute symptomatic seizures in the different treatment groups.

From: Intravenous thrombolysis or mechanical thrombectomy do not increase risk of acute symptomatic seizures in patients with ischemic stroke

 

IVT+ with seizures (n = 199)

IVT− with seizures (n = 237)

p

% Valid records

IVT+ versus IVT− patients

Acute symptomatic seizure frequency

1.5%

1.8%

0.07

100

Age (SD)

75.8 (11.6)

73.6 (12.1)

0.05

100

Female gender

102 (51.5%)

122 (51.3%)

1.0

100

Mean NIHSS at admission (SD)

9.2 (6.3)

8.8 (6.5)

 < 0.001

96

Median mRS before admission (range)

0 (0–5)

0 (0–5)

0.75

96.1

Arterial hypertension

176 (94.1%)

199 (90.9%)

0.22

93.1

Diabetes mellitus

49 (42.2%)

58 (41.1%)

0.86

58.9

Previous stroke

45 (41.6%)

70 (49.0%)

0.25

57.6

Non-neurological infection

28 (38.9%)

34 (39.1%)

0.98

36.5

 

IVT+MT+ with seizures (n = 17)

IVT+MT− with seizures (n = 17)

p

% Valid records

IVT+MT+ versus IVT+MT− patients

Acute symptomatic seizure frequency

1.7%

1.7%

1

100

Age (SD)

73.7 (10.5)

71.4 (12.7)

0.55

100

Female gender

8 (47.1%)

11 (64.7%)

0.30

100

Mean NIHSS at admission (SD)

14.1 (6.4)

13.8 (6.4)

0.407

100

Median mRS before admission (range)

0 (0–3)

0 (0–4)

0.12

100

Arterial hypertension

14 (93.3%)

14 (87.5%)

0.58

91.2

Diabetes mellitus

6 (87.5%)

2 (14.3%)

 < 0.001

61.8

Previous stroke

1 (50%)

2 (16.7%)

0.29

58.8

Non-neurological infection

7 (58.3%)

0

0.04

47.1

  1. Bold values indicate significant findings.
  2. IVT+, patients from group with intravenous thrombolysis; IVT−, patients from matched group without any recanalization procedures; IVT+MT+, patients from group with intravenous thrombolysis and mechanical thrombectomy; IVT+MT−, patients from matched group with intravenous thrombolysis and without mechanical thrombectomy; mRS, modified Rankin Scale; SD, standard deviation.